Schlenk, R. F., Harrison, C. N., Palandri, F., De Gobbi, M., Itri, F., Rampal, R., Talaulikar, D., Jacoby, B., Aslanis, V., Slack, R. J., Roper, J. A., Schambye, H. T., Singh, B. and Mascarenhas, J. (2020) “GB2064 (lenumlostat) shows preliminary evidence of bone marrow collagen fibrosis reduction with manageable tolerability in JAK inhibitor-refractory myelofibrosis: results from the MYLOX-1 phase IIa study”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.289108.